Drugs / SuperBio probiotic
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04266106 | Feb 2020 → Jun 2021 | — | Jan Franko, MD | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SuperBio probiotic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04266106 ↗ |
| Modality | Other / unclassified | “probiotic” NCT04266106 ↗ |
| Route | Oral | “One capsule po BID for 28 days” NCT04266106 ↗ |